These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33876094)

  • 1. Characterizing an allosteric inhibitor-induced inactive state in with-no-lysine kinase 1 using Gaussian accelerated molecular dynamics simulations.
    Jonniya NA; Sk MF; Kar P
    Phys Chem Chem Phys; 2021 Mar; 23(12):7343-7358. PubMed ID: 33876094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating specificity of an allosteric inhibitor WNK476 among With-No-Lysine kinase isoforms using molecular dynamic simulations.
    Amarnath Jonniya N; Sk MF; Kar P
    Chem Biol Drug Des; 2021 Sep; 98(3):405-420. PubMed ID: 33969941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the molecular choreography of Janus kinase 2 inhibition via Gaussian accelerated molecular dynamics simulations: a dynamic odyssey.
    Sk MF; Samanta S; Poddar S; Kar P
    J Comput Aided Mol Des; 2024 Feb; 38(1):8. PubMed ID: 38324213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of structural and conformational properties of WNK kinase isoforms bound to an inhibitor: insights from molecular dynamic simulations.
    Jonniya NA; Sk MF; Kar P
    J Biomol Struct Dyn; 2022 Feb; 40(3):1400-1415. PubMed ID: 33016858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cheminformatics Analysis of Dynamic WNK-Inhibitor Interactions.
    Kuenemann MA; Fourches D
    Mol Inform; 2018 Jul; 37(6-7):e1700138. PubMed ID: 29473325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating specificity of the anti-hypertensive inhibitor WNK463 against With-No-Lysine kinase family isoforms via multiscale simulations.
    Jonniya NA; Kar P
    J Biomol Struct Dyn; 2020 Mar; 38(5):1306-1321. PubMed ID: 31017050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A.
    Olivieri C; Wang Y; Walker C; Subrahmanian MV; Ha KN; Bernlohr D; Gao J; Camilloni C; Vendruscolo M; Taylor SS; Veglia G
    Elife; 2024 Jun; 12():. PubMed ID: 38913408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration and Comparison of the Geometrical and Physicochemical Properties of an αC Allosteric Pocket in the Structural Kinome.
    Sturm N; Tinivella A; Rastelli G
    J Chem Inf Model; 2018 May; 58(5):1094-1103. PubMed ID: 29697977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the structural mechanism for PKBα allosteric inhibition by molecular dynamics simulations and free energy calculations.
    Chen SF; Cao Y; Han S; Chen JZ
    J Mol Graph Model; 2014 Mar; 48():36-46. PubMed ID: 24374242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.
    Burgess SG; Oleksy A; Cavazza T; Richards MW; Vernos I; Matthews D; Bayliss R
    Open Biol; 2016 Jul; 6(7):. PubMed ID: 27411893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of regulation of the atypical protein kinase C by N-terminal domains and an allosteric small compound.
    Zhang H; Neimanis S; Lopez-Garcia LA; Arencibia JM; Amon S; Stroba A; Zeuzem S; Proschak E; Stark H; Bauer AF; Busschots K; Jørgensen TJ; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2014 Jun; 21(6):754-65. PubMed ID: 24836908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Phosphorylation-Induced Conformational Changes in WNK1 Kinase by Molecular Dynamics Simulations.
    Jonniya NA; Sk MF; Kar P
    ACS Omega; 2019 Oct; 4(17):17404-17416. PubMed ID: 31656913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsecond molecular dynamics simulations provide insight into the ATP-competitive inhibitor-induced allosteric protection of Akt kinase phosphorylation.
    Mou L; Cui T; Liu W; Zhang H; Cai Z; Lu S; Gao G
    Chem Biol Drug Des; 2017 May; 89(5):723-731. PubMed ID: 27797456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation.
    Tamirat MZ; Koivu M; Elenius K; Johnson MS
    PLoS One; 2019; 14(9):e0222814. PubMed ID: 31536605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Characterization of Allosteric WNK Kinase Inhibitors.
    Yamada K; Zhang JH; Xie X; Reinhardt J; Xie AQ; LaSala D; Kohls D; Yowe D; Burdick D; Yoshisue H; Wakai H; Schmidt I; Gunawan J; Yasoshima K; Yue QK; Kato M; Mogi M; Idamakanti N; Kreder N; Drueckes P; Pandey P; Kawanami T; Huang W; Yagi YI; Deng Z; Park HM
    ACS Chem Biol; 2016 Dec; 11(12):3338-3346. PubMed ID: 27712055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A.
    Olivieri C; Wang Y; Walker C; Subrahmanian MV; Ha KN; Bernlohr DA; Gao J; Camilloni C; Vendruscolo M; Taylor SS; Veglia G
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models.
    Yamada K; Levell J; Yoon T; Kohls D; Yowe D; Rigel DF; Imase H; Yuan J; Yasoshima K; DiPetrillo K; Monovich L; Xu L; Zhu M; Kato M; Jain M; Idamakanti N; Taslimi P; Kawanami T; Argikar UA; Kunjathoor V; Xie X; Yagi YI; Iwaki Y; Robinson Z; Park HM
    J Med Chem; 2017 Aug; 60(16):7099-7107. PubMed ID: 28771350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitors allosterically disrupt a regulatory interaction to enhance PKCα membrane translocation.
    Lippert LG; Ma N; Ritt M; Jain A; Vaidehi N; Sivaramakrishnan S
    J Biol Chem; 2021; 296():100339. PubMed ID: 33508318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies.
    Zhou Y; Zhang N; Qi X; Tang S; Sun G; Zhao L; Zhong R; Peng Y
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.
    Schröder M; Tan L; Wang J; Liang Y; Gray NS; Knapp S; Chaikuad A
    Cell Chem Biol; 2020 Oct; 27(10):1285-1295.e4. PubMed ID: 32783966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.